Duration

• 26 May – 07 Aug 2026.

The Position

We’re looking for a motivated, strategic, and curious MBA candidate to join us for the summer and support key work in launch strategy and disease state awareness. This internship offers the opportunity to roll up your sleeves and contribute to high-impact projects that sit at the center of our commercial planning efforts. 

Responsibilities

Launch Strategy and Planning 

• Support cross-functional planning as we prepare for a potential first-in-class combination launch. 

• Assist with organizing key workstreams, refining timelines, and helping keep teams aligned on what needs to happen—and when. 

• Develop go-to market, customer segmentation and adoption strategies to help maximize our launch opportunities 

• Contribute to internal presentations and updates that highlight progress, insights, and areas where strategic choices can make a difference. 

Disease State Awareness & Market Education 

• Help develop and refine the overall myelofibrosis disease narrative, including unmet needs and gaps in the current treatment landscape. 

• Dive into research—market trends, competitive insights, audience perspectives, and external data—to help us better understand how HCPs, patients, and advocacy groups think about MF today. 

• Identify opportunities to elevate disease understanding and urgency through thoughtful messaging, content, and education. 

• Support development of stakeholder personas and segmentation work. 

Requirements

• A current MBA student with an interest in healthcare, biotech, oncology, or commercial strategy. 

• Analytical and curious—you enjoy digging into data and asking good questions. 

• A strong communicator who can take complex information and turn it into something that’s easy to understand. 

• Someone who works well with others, stays organized, and is excited by meaningful, fast-moving work. 

• Experience in consulting, marketing, life sciences, or healthcare strategy is a plus but not required.
• Must be able to complete the Karyopharm Internship Program 26 May – 07 Aug 2026 
• Currently enrolled high school or college (bachelor’s program) student 
• Student must be returning to school in the Fall Term. 
• Must have a minimum GPA of 3.0 
• Must be highly organized and have the ability to work inindependently and collaboratively as a team 
• Clear, concise verbal & written communication 

Company

Karyopharm Therapeutics is a commercial-stage oncology company focused on developing novel therapies for patients with cancer, particularly in areas where treatment options have remained limited for far too long. Our team is driven by curiosity, urgency, and the belief that meaningful innovation can reshape patients’ lives. 

We are now preparing for what could become the first new combination therapy for myelofibrosis—a milestone that has the potential to change the treatment landscape and improve outcomes for people living with a challenging and under-recognized disease. It’s an incredibly exciting time to join our MF team as we build toward this potential launch.